§ Funding Round
Series B funding round for Endeavor BioMedicines raising $100M in February 2022
Series B funding round for Endeavor BioMedicines raising $100M in February 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Omega Funds | — | — |
RA Capital | — | — |
| Organization | — | |
andrew lamLEAD | Angel | andrew lam |
TriWise CapitalLEAD | Organization | — |
monal mehtaLEAD | Angel | monal mehta |
| Angel | patrick enright | |
| Organization | — | |
Piper Heartland Healthcare Capital | — | — |
| Organization | — | |
| Organization | — | |
T. Rowe Price Associates | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$292M
Top Valuation
-
Endeavor BioMedicines raised $100M in a Series B round.
The round was announced on 02/01/22.
The round was led by andrew lam, TriWise Capital, monal mehta.
